培力控股(01498.HK)預期2019財年業績盈轉虧至不少於1.4億港元
格隆匯1月22日丨培力控股(01498.HK)公告,預期集團於2019財政年度將錄得虧損淨額不少於1.4億港元,而截至2018年12月31日止年度則錄得經審核綜合純利約2080萬港元。
2019財政年度預期虧損淨額主要源於(其中包括)以下項目:(i)由於2019年香港社會動盪不安,香港診所業務全年將錄得重大虧損。本集團診所的求診人數亦大幅減少;(ii)集團的香港中藥保健品業務銷售額及盈利能力下跌,此乃由於零售市場艱難及消費意欲疲弱;(iii)於2019年初對中國濃縮中藥配方顆粒業務的定價及策略進行結構性調整,導致喪失部分無利可圖的分銷商,且暫時流失銷售額。本集團中國濃縮中藥配方顆粒業務的表現於2019財政年度下半年有所改善,惟整體銷售額仍低於去年水平;及(iv)集團種植分部預期將於2019財政年度錄得虧損,此乃由於生草藥貿易競爭激烈及利潤率偏低。
此外,集團於去年就種植分部的生物資產錄得重大公允價值收益,集團預期生物資產公允價值於2019財政年度將轉盈為虧。
另外,考慮到最近幾個月香港經營環境極其嚴峻以及本集團的財務表現,集團已進一步作出若干一次性會計撥備及撇銷(為數不少於7000萬港元,包括以下各項),亦為預期年內出現虧損的原因:(a)就香港及中國錄得虧損的診所的物業、廠房及設備以及使用權資產計提減值虧損。本集團將透過關閉地點欠佳的診所,進一步優化香港診所網絡及提升其盈利能力;(b)就本集團於香港的診所及中藥保健品業務所產生税項虧損終止確認遞延税項資產;及(c)就本集團種植分部計提商譽減值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.